Lennar Corporation, together with its subsidiaries, operates as a homebuilder primarily under the Lennar brand in the United States. It operates through Homebuilding East, Homebuilding Central, Homebuilding Texas, Homebuilding West, Financial Services, Multifamily, and Lennar Other segments. The company's homebuilding operations include the construction and sale of single-family attached and detached homes, as well as the purchase, development, and sale of residential land; and development, construction, and management of multifamily rental properties. It also offers residential mortgage financing, title, insurance, and closing services for home buyers and others, as well as originates and sells securitization commercial mortgage loans. In addition, the company is involved in the fund investment activity. It primarily serves first-time, move-up, active adult, and luxury homebuyers. The company was founded in 1954 and is based in Miami, Florida.

Lennar Corporation Class A

LENZ Therapeutics ( ($LENZ) ) just unveiled an announcement. LENZ Therapeutics, Inc. addressed a recent adverse event report submitted to the FDA’s...

LENZ Therapeutics Responds to FDA Adverse Event Report

Lennar received a Sell rating and a $98.00 price target from Barclays analyst Matthew Bouley today. Bouley covers the Industrials sector, focusing ...

Barclays downgrades Lennar (LEN) to a Sell

Citi analyst Yigal Nochomovitz maintained a Buy rating on LENZ Therapeutics on December 4 and set a price target of $52.00. The company’s shares cl...

LENZ Therapeutics (LENZ) Receives a Buy from Citi

In a report released on December 3, Ben Davis from RBC Capital reiterated a Buy rating on Glencore, with a price target of p320.00. The company’s s...

RBC Capital Sticks to Their Buy Rating for Glencore (GLEN)

Analysts are intrested in these 5 stocks: ( ($LEN) ), ( ($PFE) ), ( ($NET) ), ( ($SYM) ) and ( ($WDAY) ). Here is a breakdown of their recent


Lennar, Pfizer, Cloudflare, Symbotic, Workday: Trending by Analysts

In a report released today, Ephrem Ravi from Citi maintained a Buy rating on Glencore, with a price target of £4.40. Ravi covers the Basic Material...

Citi Remains a Buy on Glencore (GLEN)

RBC Capital analyst Ben Davis maintained a Buy rating on Glencore on November 21 and set a price target of p320.00. The company’s shares closed yes...

New Buy Rating for Glencore (GLEN), the Basic Materials Giant

In a report released yesterday, from CICC maintained a Buy rating on Lenovo Group, with a price target of HK$14.80. The company’s shares closed yes...

CICC Reaffirms Their Buy Rating on Lenovo Group (LNVGF)

In a report released yesterday, from Huatai Securities maintained a Buy rating on Lenovo Group, with a price target of HK$14.00. The company’s shar...

Huatai Securities Keeps Their Buy Rating on Lenovo Group (LNVGF)

Lenovo Group ( ($LNVGF) ) has released its Q2 earnings. Here is a breakdown of the information Lenovo Group presented to its investors. Lenovo Grou...

Lenovo Reports Record Revenue and Profit Growth

Lenovo Group ( ($HK:0992) ) has provided an update. Lenovo Group Limited announced record financial results for the first half of FY2025/26, with r...

Lenovo Reports Record Revenue and Profit Growth in FY2025/26 Interim Results

In a report released today, Ephrem Ravi from Citi maintained a Buy rating on Glencore, with a price target of £4.40. According to TipRanks, Ravi is...

Glencore (GLEN): New Buy Recommendation for This Basic Materials Giant

The famed investor has never had a down year in the market. 


AMZN, GOOGL, META: Billionaire Investor Stanley Druckenmiller Buys Into AI Trade

Lennar ( ($LEN) ) has issued an update. On November 12, 2025, Lennar Corporation announced the retirement of Jonathan M. Jaffe, Co-Chief Executive ...

Market Cap	$30.78B	P/E Ratio	14.47
52W High	$151.75	52W Low	$98.42
Div Yield	200.0%	Payout Ratio	77.3%
EPS Growth 3Y	0.1%	52W Position	39.3%
Overall Score	63	Value Score	100
Quality Score	71	Technical Score	18

EPS Current Est	$8.25	EPS Next Est	$9.06
EPS Growth Est	+9.8%	DPS Growth 3Y	10.1%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LEN	$119.37	+0.18%	2.44M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LEN	$119.37	+0.2%	2.44M
3
4
5
6

LEN

LEN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Lennar Corporation Class A Data in Excel

Get Lennar Corporation Class A Data in Excel